GlaxoSmithKline CEO Continues Restructuring With Job Cuts in Africa Post author:Sam Post published:January 17, 2018 Post category:BioPharma This Latest move is a wide-ranging effort to boost competitiveness. Source: BioSpace You Might Also Like Zafgen Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) October 12, 2017 Future Biotech Giants: 11 Life Science Entrepreneurs Under 30 February 22, 2017 Better Late Than Never: Novartis, Momenta Win FDA Approval for Delayed MS Drug February 12, 2018
